You can buy or sell GLSI and other stocks, options, and ETFs commission-free!
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX. The listed name for GLSI is Greenwich LifeSciences, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 9, Pre-Market